Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-α via the PI 3-kinase-Akt signaling pathway

Hepatology

Volumn 35, Issue 2, 2002, Pages 393-402

  Kawanaka, Hirofumi ^a,b,c   Jones, Michael K ^a,b   Szabo, Imre L ^a,b   Baatar, Dolgor ^a,b   Pai, Rama ^a,b   Tsugawa, Kouji ^a,b,c   Sugimachi, Keizo ^c   Sarfeh, I James ^a,b   Tarnawski, Andrzej S ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STOMACH MUCOSA; VASCULAR ENDOTHELIUM;

EID: 0036151948     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30958     Document Type: Article

References (50)

1. Results of surgical management of hemorrhagic gastritis in patients with gastroesophageal varices
2. Natural history of congestive gastropathy in cirrhosis
3. Portal hypertensive gastropathy
4. Portal hypertension and gastric mucosal injury in rats. Effects of alcohol
5. The portal hypertensive gastric mucosa: Histologic, ultrastructual, and functional analysis after aspirin induced damage
6. Microvascular abnormalities of the portal hypertensive gastric mucosa
7. Impaired oxygenation of gastric mucosa in portal hypertension: The basis for increased susceptibility to injury
8. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats
9. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
10. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats
11. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats
12. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rats: A key to increased susceptibility to damage?
13. Tumor necrosis factor α regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats
14. Tumor necrosis factor alpha: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats
15. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats
16. Nitric oxide: Physiology, patho-physiology, and pharmacology
17. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
18. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells
19. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells
20. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress
21. Pulsatile stretch and shear stress: Physical stimuli determining the production of endothelium-derived relaxing factors
22. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
23. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
24. The Akt kinase signals directly to endothelial nitric oxide synthase
25. Characterization of two 85 kD proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase
26. Phosphatidylinositol 3-kinase: Structure and expression of the 110 kD catalytic subunit
27. Signalling through the lipid products of phosphoinositide-3-OH kinase
28. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
29. PI3K: Downstream AKTion blocks apoptosis
30. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
31. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway
32. Isolation and characterization of rat gastric microvascular cells as a model for studying gastric angiogenesis in vitro
33. Induction of mitogen-activated protein kinase signal transduction pathway during gastric ulcer healing in rats
34. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways
35. A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase
36. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites
37. Vascular nitric oxide production during the development of two experimental models of portal hypertension
38. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats
39. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites
40. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity
41. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats
42. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension
43. Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: Implications for endothelial dysfunction and vascular biology
44. Nitric oxide synthases: Which, where, how, and why?
45. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
46. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
47. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI 3-kinase pathway in human endothelial cells
48. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension
49. Dynamic activation of endothelial nitric oxide synthase by Hsp90
50. Reconstitution of an endothelial nitric oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1